This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Naehle, C. P. Articles by Sommer, T. Search for Related Content PubMed PubMed Citation Articles by Naehle, C. P. Articles by Sommer, T. Related Collections Related Articles

CLINICAL RESEARCH: CARDIAC IMAGING

Magnetic Resonance Imaging at 1.5-T in Patients With Implantable Cardioverter-Defibrillators

Claas P. Naehle, MD^_*,_*, Katharina Strach, MD^_*, Daniel Thomas, MD^_*, Carsten Meyer, MD^_*, Markus Linhart, MD, Sascha Bitaraf, MD, Harold Litt, MD, PhD, Jörg Otto Schwab, MD, Hans Schild, MD^_* and Torsten Sommer, MD^||

^_* Department of Radiology, University of Bonn, Bonn, Germany
Department of Cardiology, University of Bonn, Bonn, Germany
Department of Internal Medicine–Cardiology, Katholisches Klinikum Koblenz–Marienhof, Koblenz, Germany
Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
^|| Department of Radiology, German Red Cross Hospital, Neuwied, Germany

Manuscript received January 22, 2009; revised manuscript received March 9, 2009, accepted April 15, 2009.

^_* Reprint requests and correspondence: Dr. Claas P. Naehle, Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany (Email: cp{at}naehle.net).

Objectives: Our aim was to establish and evaluate a strategy for safe performance of magnetic resonance imaging (MRI) at 1.5-T in patients with implantable cardioverter-defibrillators (ICDs).

Background: Expanding indications for ICD placement and MRI becoming the imaging modality of choice for many indications has created a growing demand for MRI in ICD patients, which is still considered an absolute contraindication.

Methods: Non–pacemaker-dependent ICD patients with a clinical need for MRI were included in the study. To minimize radiofrequency-related lead heating, the specific absorption rate was limited to 2 W/kg. ICDs were reprogrammed pre-MRI to avoid competitive pacing and potential pro-arrhythmia: 1) the lower rate limit was programmed as low as reasonably achievable; and 2) arrhythmia detection was programmed on, but therapy delivery was programmed off. Patients were monitored using electrocardiography and pulse oximetry. All ICDs were interrogated before and after the MRI examination and after 3 months, including measurement of pacing capture threshold, lead impedance, battery voltage, and serum troponin I.

Results: Eighteen ICD patients underwent a total of 18 MRI examinations at 1.5-T; all examinations were completed safely. All ICDs could be interrogated and reprogrammed normally post-MRI. No significant changes of pacing capture threshold, lead impedance, and serum troponin I were observed. Battery voltage decreased significantly from pre- to post-MRI. In 2 MRI examinations, oversensing of radiofrequency noise as ventricular fibrillation occurred. However, no attempt at therapy delivery was made.

Conclusions: MRI of non–pacemaker-dependent ICD patients can be performed with an acceptable risk/benefit ratio under controlled conditions by taking both MRI- and pacemaker-related precautions. (Implantable Cardioverter Defibrillators and Magnetic Resonance Imaging of the Heart at 1.5-Tesla; NCT00356239)

Key Words: magnetic resonance imaging • implantable cardioverter-defibrillator • safety

Abbreviations and Acronyms   ATP = antitachycardia pacing   DC = direct current   ICD = implantable cardioverter-defibrillator   MRI = magnetic resonance imaging   PM = pacemaker   RF = radiofrequency   SAR = specific absorption rate

Related Articles

Magnetic Resonance Imaging in Patients With Implantable Cardioverter-Defibrillators and Pacemakers

Ariel Roguin
J. Am. Coll. Cardiol. 2009 54: 556-557. [Full Text] [PDF]

This article has been cited by other articles:

				M. J. Junttila, J. E. Fishman, G. A. Lopera, P. M. Pattany, D. L. Velazquez, A. R. Williams, B. H. Trachtenberg, C. Sanina, J. Mather, and J. M. Hare Safety of serial MRI in patients with implantable cardioverter defibrillators Heart, November 15, 2011; 97(22): 1852 - 1856. [Abstract] [Full Text] [PDF]

				T. Sasaki, R. Hansford, M. M. Zviman, A. Kolandaivelu, D. A. Bluemke, R. D. Berger, H. Calkins, H. R. Halperin, and S. Nazarian Quantitative Assessment of Artifacts on Cardiac Magnetic Resonance Imaging of Patients With Pacemakers and Implantable Cardioverter-Defibrillators Circ Cardiovasc Imaging, November 1, 2011; 4(6): 662 - 670. [Abstract] [Full Text] [PDF]

				S. Nazarian, R. Hansford, A. Roguin, D. Goldsher, M. M. Zviman, A. C. Lardo, B. S. Caffo, K. D. Frick, M. A. Kraut, I. R. Kamel, et al. A Prospective Evaluation of a Protocol for Magnetic Resonance Imaging of Patients With Implanted Cardiac Devices Ann Intern Med, October 4, 2011; 155(7): 415 - 424. [Abstract] [Full Text] [PDF]

				E. Anter, M. D. Hutchinson, R. Deo, H. M. Haqqani, D. J. Callans, E. P. Gerstenfeld, F. C. Garcia, R. Bala, D. Lin, M. P. Riley, et al. Surgical Ablation of Refractory Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy Circ Arrhythm Electrophysiol, August 1, 2011; 4(4): 494 - 500. [Abstract] [Full Text] [PDF]

				N. G. Baikoussis, E. Apostolakis, N. A. Papakonstantinou, I. Sarantitis, and D. Dougenis Safety of Magnetic Resonance Imaging in Patients With Implanted Cardiac Prostheses and Metallic Cardiovascular Electronic Devices Ann. Thorac. Surg., June 1, 2011; 91(6): 2006 - 2011. [Abstract] [Full Text] [PDF]

				T. Dickfeld, J. Tian, G. Ahmad, A. Jimenez, A. Turgeman, R. Kuk, M. Peters, A. Saliaris, M. Saba, S. Shorofsky, et al. MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium-Enhanced 3D Scar in Patients With Implantable Cardioverter-Defibrillators Circ Arrhythm Electrophysiol, April 1, 2011; 4(2): 172 - 184. [Abstract] [Full Text] [PDF]

				F. Buendia, O. Cano, J. M. Sanchez-Gomez, B. Igual, J. Osca, M. J. Sancho-Tello, J. Olague, and A. Salvador Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices Europace, April 1, 2011; 13(4): 533 - 538. [Abstract] [Full Text] [PDF]

				J. R. Gimbel The safety of MRI scanning of pacemakers and ICDs: what are the critical elements of safe scanning? Ask me again at 10 000. Europace, July 1, 2010; 12(7): 915 - 917. [Full Text] [PDF]

				A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al. Highlights of the Year in JACC 2009 J. Am. Coll. Cardiol., January 26, 2010; 55(4): 380 - 407. [Full Text] [PDF]

				Magnetic Resonance Imaging in Patients with Implantable Cardioverter-Defibrillators: The Walls Are Crumbling Journal Watch Cardiology, September 2, 2009; 2009(902): 1 - 1. [Full Text]

				A. Roguin Magnetic Resonance Imaging in Patients With Implantable Cardioverter-Defibrillators and Pacemakers J. Am. Coll. Cardiol., August 4, 2009; 54(6): 556 - 557. [Full Text] [PDF]